FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline
FDA announced an aggressive timeline to scale AI across all centers by June 30.
Related Articles
Banks increasingly active in use of artificial intelligence
Having overcome initial reticence, more and more retail banks are turning to artificial intelligence (AI) to optimise processes and offer new products.
Psychoactive drugs found in mysterious temple may have helped ancient Peruvians cement power
2500-year-old hallucinogenic rituals may have allowed ChavÃn de Huántar elites to gain prestige and influence
Cell type–specific efferocytosis determines functional plasticity of alveolar macrophages
MPO activates an immunometabolic rheostat to restrict the functional plasticity of macrophages in favor of proresolving properties.
Watch these tree frogs make some of the most dramatic landings in nature
Slow-motion videos reveal how the amphibians attach to vertical branches in midair
Learning in the Key of AI
Like music, learning in the age of AI is no longer about notes alone—it’s about the cadence we compose together.
Teaching digital health: lessons from ten semesters
Published in Journal of Communication in Healthcare: Strategies, Media and Engagement in Global Health (Vol. 16, No. 3, 2023)
Learning in the Key of AI
Like music, learning in the age of AI is no longer about notes alone—it’s about the cadence we compose together.
Tumor Antigen Reactivity Plays Important Role in TIL Therapy Efficacy
Targeting clonal antigens and circumventing dysfunctional states may be important for conferring clinical responses to TIL therapy.
Without proper data, AI can be harmful
Policymakers grapple with data scarcity and poverty, risking inequity and overhyping data-driven solutions, says Jessica Morley, postdoctoral research associate at Yale University’s Digital Ethics
